Matthew Call

Overview

Matthew Call received an average of $3M in total compensation, including $450K in salary, at iTeos Therapeutics from 2021 to 2023.

Source: SEC filings on April 25, 2024, April 27, 2023, and April 25, 2022.

Related executives

We found three more executives who work or worked at iTeos Therapeutics.

Michel Detheux

iTeos Therapeutics

Chief Executive Officer

Matthew Gall

iTeos Therapeutics

Chief Financial Officer

Joanne Lager

iTeos Therapeutics

Chief Medical Officer

News

You may also like